Fight CRC Blog

Innovation Summit Sparks Action for Advancing Colorectal Cancer Screening

On October 7-9, 2024, Fight Colorectal Cancer co-hosted with the inaugural Innovation Summit with Exact Sciences. This dynamic three-day event brought together public health leaders, advocates, researchers, and healthcare professionals...

Changing Quality Care in Colorectal Cancer

In response to the persistently high nationwide burden of colorectal cancer (CRC), Fight Colorectal Cancer (Fight CRC) has launched the Colorectal Cancer Care Initiative (CRCCI), a vital collaboration aimed at...

Early Career Award to Drive Lynch Syndrome Management

Fight Colorectal Cancer (Fight CRC) is proud to announce that its Genetics and Family History Advisory Council is leading an initiative, alongside nearly 150 patient advocacy organizations, medical societies, and...

ESMO Updates

Patients with microsatellite instability (MSI)/mismatch repair deficient (dMMR) colon cancer who undergo surgery may benefit from receiving neoadjuvant immunotherapy. Standard-of-care chemotherapy offers limited benefit to patients with MSI-H/dMMR colon cancer,...

Understanding the ERASur clinical trial

Dr. Miller: The primary objective of ERASur is to answer this question – Do patients with limited metastatic colorectal cancer live longer if we treat all sites of disease with...

Advocacy wins and survivorship

What an exciting month June has been so far! You relentlessly raised your voice alongside the GI community to object to UnitedHealthcare’s prior authorization policy. Advocates sent almost 1,200 action...